Related Experiment Video
Updated: Jun 18, 2026

Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
Cre/loxP-regulated transgenic zebrafish model for neural progenitor-specific oncogenic Kras expression
Seung-Hyeok Seok1, Yi-Rang Na, Ju-Hee Han
1Institute for Experimental Animals, College of Medicine, Seoul National University, Seoul, Korea.
Oncogenic Kras(V12) in zebrafish neural progenitors caused cell death and brain edema, but not early tumors. Some cells resisted Kras(V12) and differentiated, showing developmental timing impacts.
Area of Science:
- Developmental biology
- Molecular oncology
- Neuroscience
Background:
- Ras proteins are key regulators of cellular signaling pathways controlling proliferation, survival, and differentiation.
- The impact of oncogenic mutations on developmental timing and cellular phenotypes remains an area of active investigation.
Purpose of the Study:
- To investigate the developmental effects of oncogenic Kras(V12) activation in neural progenitor cells using a transgenic zebrafish model.
- To understand the relationship between Ras signaling, neural development, and tumor formation.
Main Methods:
- Utilized the Cre/loxP system to control oncogenic Kras(V12) expression under the nestin promoter in transgenic zebrafish.
- Confirmed Cre-mediated gene excision via polymerase chain reaction.
- Assessed Kras(V12) effects using histological analyses (hemotoxylin-eosin staining), apoptosis assays (TUNEL), and in situ hybridization.
Main Results:
- Activation of Kras(V12) in neural progenitors led to severe brain edema and massive apoptosis, causing early embryonic lethality.
- Despite Kras(V12) overexpression, some neural progenitor cells retained the ability to differentiate into neurons.
- The study's transgenic model indicated that Kras(V12) alone is insufficient to induce brain tumors during early development.
Conclusions:
- Overexpression of Kras(V12) in neural progenitor cells results in significant apoptosis and brain edema, leading to early death.
- Neural progenitor cells exhibit varying sensitivity to oncogenic Kras(V12), with some capable of differentiation.
- This model highlights that Kras(V12) activation alone does not drive early-stage brain tumor formation in this context.
More Related Videos
08:52Live Imaging of Innate Immune and Preneoplastic Cell Interactions Using an Inducible Gal4/UAS Expression System in Larval Zebrafish Skin
Published on: February 3, 2015
09:45Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015